Effectiveness results of olanzapine in acute psychotic patients with agitation in the emergency room setting: Results from NATURA study

Actas Espanolas de Psiquiatria

Volumn 36, Issue 3, 2008, Pages 151-157

  Escobar, R ^a   San, L ^b   Perez V ^c   Olivares, J M ^d   Polavieja, P ^a   Lopez Carrero C ^a   Casillas, M ^a   Montoya, A ^a  

^a ELI LILLY AND COMPANY   (Spain)

^b HOSPITAL SAN RAFAEL   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d NONE

Author keywords

Agitation; Emergency medical services; Olanzapine; Schizophrenia

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; OLANZAPINE;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; PSYCHOSIS; QUESTIONNAIRE; RESTLESSNESS;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMERGENCY SERVICES, PSYCHIATRIC; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; QUESTIONNAIRES;

EID: 46249131107     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Allen MH, Currier GW. Use of restraints and pharmacotherapy in academic psychiatric emergency services. Gen Hosp Psychiatry 2004;26:42-9.
2. De Fruyt J, Demyttenaere K. Rapid tranquilization: new approaches in the emergency treatment of behavioral disturbances. Europ Psychiatry 2004;19:243-9.
3. Hughes DH, Kleespies M. Treating agression in the psychiatric emergency service. J Clin Psychiatry 2003;64(Suppl. 4):10-15.
4. Yildiz A, Sachs GS, Turgay A. Pharmacological management of agitation in emergency settings. Emerg Med J 2004;21:649.
5. a ed. Barcelona: Ars Médica, 2005.
6. Schwartz JT, Brotman AW. A clinical guide to antipsychotic drugs. Drugs 1992;44:981-92.
7. Anon. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry 1998;59(Suppl. 12):23-7.
8. Kamin J, Manwani S, Hughes D. Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service. Psychiatr Serv 2000;51:287-9.
9. Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. Treatment of behavioral emergencies 2005. J Psychiatr Pract 2005;11(Supp. 1):5-108;quiz 110-2.
10. Pascual JC, Madre M, Puigdemont D. A naturalistic study: 100 consecutive episodes of acute agitation in psychiatric emergency department. Actas Esp Psiquiatr 2006;34:239-44.
11. Rund DA, Swing JD, Mitzel K, Votolato N. The use of intramolecular benzdiazepines and antipsychotic agents in the treatment of acute agitation or violence in the emergency department. J Emerg Med 2006;31:317-24.
12. Consejería de Sanidad y Consumo. Dirección General de Farmacia y Productos Sanitarios. Comunidad de Madrid. Recomendaciones terapéuticas para el manejo de la agresividad. En: Recomendaciones Farmacoterapéuticas en Salud Mental 2004;1: 1-11.
13. Kinon BJ, Hill AL, Liu H, Kollack-Walker S. Olanzapine orally disintegrating tablets in the treatment of acutely ill non-compliant patients with schizophrenia. Int J Neuropsychopharmacol 2003;6:97-102.
14. Currier GW, Trenton A. Pharmacological treatment of psychotic agitation. CNS Drugs 2002;16:219-28.
15. Guy W. Clinical global impressions (CGI). En: Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology, Revised. Rockville: U.S. Department of Health, Education, and Welfare, National Institute of Mental Health, Psychopharmacology Research Branch, 1976:217-22.
16. Kay SR, Sevy S. Pyramidical model of schizophrenia. Schizophr Bull 1990;16:537-45.
17. Meehan KM, Wang H, David SR. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology 2002;26:494-504.
18. Wright P, Meehan K, Birkett M. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clin Ther 2003;25: 1420-8.
19. Jiménez MT, Arago J, Nuno A, Lono J, Ochando G. Management of agitated, violent or psychotic patients in the emergency department: an overdue protocol for an increasing problem. An Pediatr 2005;63:526-36.
20. Battaglia J, Lindborg SR, Alaka K. Calming versus sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med 2003;21:192-8.
21. Allen MH. Managing the agitated psychotic patient: a reappraisal of the evidence. J Clin Psychiatry 2000;61(Suppl. 14):11-20.
22. Johnson D, Rai S, Milne S. Olanzapine oro-dispersible (Velotab™) an alternative to depot? Inter J Psychiatry Clin Pract 2002;6: 163-5.
23. Safont G, Pérez Sola V, Montejo G, Pascual JC, Puigdemont D, Álvarez E. Naturalistic study of the effectiveness and safety of 20 mg of orally disintegrating olanzapine in the treatment of patients with severe agitation. Poster at the ECNP, 2003, Prague. From Psychiatry Department. Hospital de la Santa Creu i Sant Pau. Barcelona. Spain.
24. Kinon BJ. Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. Am J Emerg Med 2004;22:181-6.